发布求助
文献互助 智能选刊 最新文献

Australian Prescriber最新文献

筛选
英文 中文
Toxic interaction between atorvastatin and clarithromycin causing myositis and rhabdomyolysis. 阿托伐他汀和克拉霉素的毒性相互作用引起肌炎和横纹肌溶解。
IF 4.2
Australian Prescriber Pub Date : 2026-04-01 DOI: 10.18773/austprescr.2026.013
Mitchel Hurlbert, Tien Tay, Cameron J Holloway, Laila Girgis
{"title":"Toxic interaction between atorvastatin and clarithromycin causing myositis and rhabdomyolysis.","authors":"Mitchel Hurlbert, Tien Tay, Cameron J Holloway, Laila Girgis","doi":"10.18773/austprescr.2026.013","DOIUrl":"https://doi.org/10.18773/austprescr.2026.013","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"49 2","pages":"68-69"},"PeriodicalIF":4.2,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13095490/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147790315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic dysfunction-associated fatty liver disease: an update. 代谢功能障碍相关的脂肪肝疾病：最新进展
IF 4.2
Australian Prescriber Pub Date : 2026-04-01 DOI: 10.18773/austprescr.2026.014
Richard O'Halloran, Leon A Adams, Gary Deed, John S Lubel
{"title":"Metabolic dysfunction-associated fatty liver disease: an update.","authors":"Richard O'Halloran, Leon A Adams, Gary Deed, John S Lubel","doi":"10.18773/austprescr.2026.014","DOIUrl":"https://doi.org/10.18773/austprescr.2026.014","url":null,"abstract":"<p><p>Metabolic dysfunction-associated fatty liver disease (MAFLD) affects 1 in 3 Australian adults and is an under-recognised but growing cause of liver cirrhosis, hepatocellular carcinoma and liver transplantation. There is a major role for primary care in MAFLD prevention, diagnosis and management. Adults with obesity, type 2 diabetes or other metabolic risk factors should be assessed for MAFLD. Liver ultrasound is the recommended first-line test for diagnosing hepatic steatosis (fat accumulation in hepatocytes). Management of MAFLD includes noninvasive testing for liver fibrosis, addressing health risk behaviours and comorbidities, and hepatocellular carcinoma surveillance in those with liver cirrhosis.</p>","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"49 2","pages":"44-49"},"PeriodicalIF":4.2,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13095493/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147790220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Foslevodopa+foscarbidopa for advanced Parkinson disease. Foslevodopa+foscarbidopa治疗晚期帕金森病。
IF 4.2
Australian Prescriber Pub Date : 2026-04-01 DOI: 10.18773/austprescr.2026.015
{"title":"Foslevodopa+foscarbidopa for advanced Parkinson disease.","authors":"","doi":"10.18773/austprescr.2026.015","DOIUrl":"https://doi.org/10.18773/austprescr.2026.015","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"49 2","pages":"74-75"},"PeriodicalIF":4.2,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13095489/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147790171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adrenaline (epinephrine) nasal spray for severe allergic reactions. 肾上腺素（肾上腺素）鼻喷雾剂用于严重过敏反应。
IF 4.2
Australian Prescriber Pub Date : 2026-04-01 DOI: 10.18773/austprescr.2026.010
{"title":"Adrenaline (epinephrine) nasal spray for severe allergic reactions.","authors":"","doi":"10.18773/austprescr.2026.010","DOIUrl":"https://doi.org/10.18773/austprescr.2026.010","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"49 2","pages":"72-73"},"PeriodicalIF":4.2,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13095492/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147790187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitamin B12 deficiency: testing and treatment. 维生素B12缺乏症：检测和治疗。
IF 4.2
Australian Prescriber Pub Date : 2026-04-01 DOI: 10.18773/austprescr.2026.012
Darya Bedz, Cecily Forsyth
{"title":"Vitamin B12 deficiency: testing and treatment.","authors":"Darya Bedz, Cecily Forsyth","doi":"10.18773/austprescr.2026.012","DOIUrl":"https://doi.org/10.18773/austprescr.2026.012","url":null,"abstract":"<p><p>Vitamin B12 testing is recommended for individuals with clinical signs and symptoms suggestive of B12 deficiency, and when there is reasonable clinical suspicion of deficiency due to risk factors (e.g. inadequate dietary intake, malabsorptive conditions). Where vitamin B12 testing is indicated, total serum B12 is typically the first-line test. Active B12 may be requested if total B12 results are indeterminate, or during pregnancy. If total or active B12 tests are inconclusive, methylmalonic acid or homocysteine testing may be considered; however, their concentrations may be elevated in other conditions. In individuals with confirmed B12 deficiency, B12 supplementation is required, with the choice of formulation, duration and dosage guided by the underlying cause and severity of the deficiency and patient preference.</p>","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"49 2","pages":"55-60"},"PeriodicalIF":4.2,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13095491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147790348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Measuring blood pressure accurately. 准确测量血压。
IF 4.2
Australian Prescriber Pub Date : 2026-04-01 DOI: 10.18773/austprescr.2026.016
Anastasia S Mihailidou
{"title":"Measuring blood pressure accurately.","authors":"Anastasia S Mihailidou","doi":"10.18773/austprescr.2026.016","DOIUrl":"https://doi.org/10.18773/austprescr.2026.016","url":null,"abstract":"<p><p>Accurately measuring blood pressure is imperative for diagnosis and control of hypertension. There is a range of devices and methods for measuring blood pressure that each have advantages and limitations. To ensure accuracy of blood pressure measurement and hypertension diagnosis, clinicians and patients should use an accurate and validated blood pressure measurement device, an appropriately sized cuff, and take several measurements rather than only one measurement, using a standardised measurement protocol. Out-of-clinic measurement, using an ambulatory or home blood pressure monitoring device, depending on patient preference, should be used to confirm diagnosis and guide treatment of hypertension. There are emerging new technologies for blood pressure measurement (e.g. wearable technologies) that are yet to be validated and have the potential to improve blood pressure monitoring and patient self-management.</p>","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"49 2","pages":"50-54"},"PeriodicalIF":4.2,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13107338/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147790178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytomegalovirus in pregnancy: prevention, maternal screening, and the role of antivirals. 巨细胞病毒在妊娠：预防，产妇筛查，和抗病毒药物的作用。
IF 4.2
Australian Prescriber Pub Date : 2026-04-01 DOI: 10.18773/austprescr.2026.011
Lisa Hui, Natasha E Holmes, Michelle L Giles, William Rawlinson
{"title":"Cytomegalovirus in pregnancy: prevention, maternal screening, and the role of antivirals.","authors":"Lisa Hui, Natasha E Holmes, Michelle L Giles, William Rawlinson","doi":"10.18773/austprescr.2026.011","DOIUrl":"https://doi.org/10.18773/austprescr.2026.011","url":null,"abstract":"<p><p>Cytomegalovirus (CMV) is the most common congenital infection in Australia and a leading cause of preventable childhood disability. Current Australian guidelines recommend targeted antenatal screening of women at higher risk for CMV infection. Serology testing should also be considered in women with clinical symptoms suggestive of CMV. Women with suspected CMV infection in pregnancy should be promptly referred to a maternal-fetal medicine or infectious diseases specialist. High-dose valaciclovir can reduce in utero transmission to the fetus following first-trimester maternal primary infection; however, long-term safety data are limited. Valaciclovir should only be prescribed by clinicians with specific expertise in CMV, such as maternal-fetal medicine or infectious diseases specialists. Universal hygiene counselling, targeted screening, careful timing of conception after infection, and structured psychological support are essential components of care.</p>","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"49 2","pages":"61-67"},"PeriodicalIF":4.2,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13095495/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147790163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sunscreen, vitamin D and skin of colour. 防晒霜，维生素D和肤色。
IF 4.2
Australian Prescriber Pub Date : 2026-04-01 DOI: 10.18773/austprescr.2026.009
{"title":"Sunscreen, vitamin D and skin of colour.","authors":"","doi":"10.18773/austprescr.2026.009","DOIUrl":"https://doi.org/10.18773/austprescr.2026.009","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"49 2","pages":"70-71"},"PeriodicalIF":4.2,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13095494/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147790206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vutrisiran for transthyretin amyloidosis. Vutrisiran用于甲状腺转维蛋白淀粉样变。
IF 4.2
Australian Prescriber Pub Date : 2026-02-01 DOI: 10.18773/austprescr.2026.001
{"title":"Vutrisiran for transthyretin amyloidosis.","authors":"","doi":"10.18773/austprescr.2026.001","DOIUrl":"https://doi.org/10.18773/austprescr.2026.001","url":null,"abstract":"","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"49 1","pages":"39-41"},"PeriodicalIF":4.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12928834/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147286401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preventing infections in immunosuppressed patients. 预防免疫抑制患者感染。
IF 4.2
Australian Prescriber Pub Date : 2026-02-01 DOI: 10.18773/austprescr.2026.003
Aadith Ashok, Aleece I MacPhail, Michelle L Giles, Bradley J Gardiner
{"title":"Preventing infections in immunosuppressed patients.","authors":"Aadith Ashok, Aleece I MacPhail, Michelle L Giles, Bradley J Gardiner","doi":"10.18773/austprescr.2026.003","DOIUrl":"https://doi.org/10.18773/austprescr.2026.003","url":null,"abstract":"<p><p>Immunosuppressed patients are vulnerable to infections which can cause significant mortality and morbidity. A dedicated evaluation, performed prior to immunosuppression where possible, can improve infection-related outcomes for these complex patients. Strategies to reduce infection risk include individualised risk assessment, targeted screening investigations, antimicrobial prophylaxis, vaccination and education to reduce future exposures to infectious pathogens.</p>","PeriodicalId":55588,"journal":{"name":"Australian Prescriber","volume":"49 1","pages":"22-29"},"PeriodicalIF":4.2,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12928835/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147286411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书